TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set October 28, 1977
TCL Archive NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board” March 11, 1983
TCL Archive Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency. January 9, 2004
